ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,110 companies indexed · Last updated: today
DirectoryIndustryMedical Technology IndustryEpalingesHedera Dx SA
Hedera Dx SA Logo
Verified· 3 sources

Hedera Dx SA

Summary

About the company

The core activity of Hedera Dx is the development and provision of liquid biopsy solutions for oncology, specifically NGS-based (Next-Generation Sequencing) solutions that can be processed in-house. The company aims to become a global provider of analytically and clinically validated liquid biopsy tests that are used in daily practice and comply with guidelines and regulatory-approved cancer treatment options.

AI-generated
Offering

Products & services

Industry:Medical Technology Industry
✓ Offered12
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
NGS tumor profiling
NGS-based tumor profiling for FFPE, fresh tissue and blood samples; detection of SNVs, indels, CNVs, fusions, MSI and biomarkers for personalised therapies.
Liquid biopsy test panels
ctDNA-based liquid biopsy test panels for solid tumors; rapid NGS analysis, DNA-only workflow, detection of SNVs, indels, CNVs, fusions and MSI.
Hedera Profiling 1 test panels
115-gene panels for common solid tumors on FFPE and ctDNA samples; detection of SNVs, indels, CNVs, fusions and MSI with a DNA-only workflow.
Hedera Profiling 2 ctDNA test panel
32-gene ctDNA panel for common solid tumors such as lung, breast and colorectal; DNA-only liquid biopsy assay with rapid analysis and MSI detection.
Hedera Profiling 3 ctDNA test panel
43-gene ctDNA panel for common solid tumors such as lung, breast, ovary and prostate; DNA-only liquid biopsy assay with rapid reporting and MSI detection.
Hedera Profiling RNA test panel
43-gene RNA panel for solid tumors; detection of fusions, gene expression profiles, alternative splicing and exon-skipping-relevant variants.
Hedera Prime software analysis
Software for pathogenicity assessment, OncoKB-supported interpretation, therapy options in the report and customisable clinical reports.
Hedera Comply implementation program
IVDR implementation program with on-site training, wet-lab instruction, run assessment, software training, validation and technical support.
Real-World Evidence
Prospective real-world evidence studies with longitudinal clinical, molecular and patient-reported data for regulation, HTA, HEOR, biomarker research and study optimisation.
Bespoke Prospective RWE Studies
Tailored prospective RWE studies for specific evidence gaps in oncology; study design, patient selection, biomarker panels and endpoints according to partner needs.
Biopharma partnerships
Partnerships with biopharma for oncology research and development; decentralised tumor profiling, RWE datasets, companion diagnostic development and biomarker validation.
Sequencing Services
NGS-based sequencing services for tumor profiling and monitoring from tissue and liquid biopsy samples; supports clinical trials, biomarker stratification and longitudinal monitoring.
Press

Media

May 27, 2025Media
Hedera Dx raises €15M to bring modern cancer care to patients worldwide
startupticker.ch
September 16, 2024Media
Positive clinical progress in the biotech scene
startupticker.ch
October 17, 2023Media
Hedera Dx Launches Blood Based Cancer Testing
startupticker.ch
September 21, 2022Media
€14 million to accelerate global adoption of liquid biopsies
startupticker.ch

Knowledge

No knowledge articles yet

Once Hedera Dx SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Hedera Dx SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Hedera Dx SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Hedera Dx SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
Route de la Corniche 5
1066 Epalinges
Opening hours
Mon
09:00 - 17:00
Tue
09:00 - 17:00
Wed
09:00 - 17:00
Thu
09:00 - 17:00
Fri
09:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-330.109.790
Founded
2021 · 5 years
Last commercial register change
February 18, 2026
Employees
11 to 20

Similar companies

LS
LifeDX SA
Epalinges
BS
BD Switzerland Sàrl
Eysins
ME
Medtronic Europe Sàrl
Tolochenaz
MB
Medtronic BioPharma Sàrl
Tolochenaz
CO
Centre orthopédique Neuchâtel S.A., succursale de Payerne
Payerne
NL
nardi lunetier sàrl
Lonay
OK
Ortho Koller SA
Vevey
LM
LA MAISON DU PIED Sàrl
Yverdon-Les-Bains